GALNT13 and neuroblastoma: As the bone marrow (BM) is the preferential site for NB dissemination, BM molecular analysis of human neuroblastoma patients has shown high expression of GALNT13, which was identified as a new indicator for disseminated neuroblasts in BM of NB patients.